Search Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupGastroenterologic OncologyGynecological OncologyThoracic TumorsTumor, regardless of entityDiseaseBreast CancerLung Carcinoma, Non-Small CellLung Carcinoma, Small CellTumor, Various OrgansSubgroupICD10C34.-C50.-MeSHBreast NeoplasmsSmall Cell Lung CarcinomaSequenceChemotherapyChemo-substanceCisplatinMitoxantroneChemo-substanceCisplatinMitoxantroneChemo-substanceCisplatinMitoxantroneChemo-substanceCisplatinMitoxantroneNo. Substances1 RadiotherapySupportive therapySupportive substanceSupportive substanceSupportive substanceSupportive substanceNo. SubstancesProtocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentionpalliativeRisksCardiotoxicityEmetogenicityLeukopeniaThrombocytopenia below 50 000/µl only studiesPublicationAuthorMaisch BMusch EDiseaseMaligner Perikarderguss, hämodynamisch relevantOriginAllgemeine Innere Medizin, Marienhospital Bottrop, GermanyDepartment of Internal Medicine-Cardiology, Philipps University, Marburg, GermanyProtocols in Revision 2 protocols foundProtocols under revision.Cisplatin 30, Tumor, Various Organs (PID2371 V1.0)Mitoxantrone 20, Tumor, Various Organs (PID2370 V1.0)
